OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study)
Saved in:
| Title: | OC-02 Gemcitabine with or without prophylactic weight-adjusted dalteparin (WAD) in patients with advanced or metastatic pancreatic cancer (APC): a multicentre, randomised phase IIB trial (the UK FRAGEM study) |
|---|---|
| Authors: | Maraveyas, A., Waters, J., Roy, R., Propper, D., Fyfe, D., Lofts, F., Bozas, G., Gardiner, E., Sgouros, J., Wedgewood, K.R. |
| Source: | Thrombosis Research. Apr2010 Supplement 2, Vol. 125, pS161-S161. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00493848 |
|---|---|
| DOI: | 10.1016/S0049-3848(10)70037-2 |
